Evolution of plasma D-dimer and fibrinogen in witnessed onset of paroxysmal atrial fibrillation

Tzong Luen Wang, Chi Ren Hung, Hang Chang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Although increased D-dimer and fibrinogen have been proved to be related with atrial fibrillation (AF), their evolution in the course of time remains unclear. Methods: To elucidate the evolution of plasma D-dimer and fibrinogen in AF of different duration. 56 patients (group A) of 3,524 patients in whom the onset of AF had been witnessed in a chest pain clinic were enrolled for study. Plasma D-dimer and fibrinogen concentrations were checked within 30 min after the onset of AF and followed up as scheduled. Another 50 patients (group B) with chronic AF underwent the same protocol and served as controls. Results: In group A, the D-dimer levels reached a plateau at the 18th hour (382 ± 52 vs. 840 ± 280 ng/ml, p <0.001 by ANOVA) and the fibrinogen level increased gradually from 4.1 ± 0.6 g/ml at baseline to 6.1 ± 0.9 g/ml at the 48th hour (p <0.001). No subjects had evidence of intra-cardiac thrombi by trans-esophageal echocardiography. There were significant differences in plasma D-dimer and fibrinogen levels between the two groups at each measurement. At the cut-off value of 500 ng/ml, plasma D-dimer had a sensitivity of 100%, a specificity of 93% in defining AF lasting for less than 12 h. The positive and negative predictive values were 52% and 100%, respectively. Plasma D-dimer increased above the normal range prior to the 12th hour after the onset of AF. Conclusion: The observations support its use as a screening tool for identifying patients with short duration AF capable of being safely converted.

Original languageEnglish
Pages (from-to)115-118
Number of pages4
JournalCardiology
Volume102
Issue number2
DOIs
Publication statusPublished - 2004
Externally publishedYes

Fingerprint

Fibrinogen
Atrial Fibrillation
Pain Clinics
fibrin fragment D
Chest Pain
Echocardiography
Analysis of Variance
Reference Values
Thrombosis

Keywords

  • Atrial fibrillation
  • D-dimer
  • Fibrinogen
  • Thromboembolism

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Evolution of plasma D-dimer and fibrinogen in witnessed onset of paroxysmal atrial fibrillation. / Wang, Tzong Luen; Hung, Chi Ren; Chang, Hang.

In: Cardiology, Vol. 102, No. 2, 2004, p. 115-118.

Research output: Contribution to journalArticle

Wang, Tzong Luen ; Hung, Chi Ren ; Chang, Hang. / Evolution of plasma D-dimer and fibrinogen in witnessed onset of paroxysmal atrial fibrillation. In: Cardiology. 2004 ; Vol. 102, No. 2. pp. 115-118.
@article{1abaae495371438294a94d0149ae56bd,
title = "Evolution of plasma D-dimer and fibrinogen in witnessed onset of paroxysmal atrial fibrillation",
abstract = "Background: Although increased D-dimer and fibrinogen have been proved to be related with atrial fibrillation (AF), their evolution in the course of time remains unclear. Methods: To elucidate the evolution of plasma D-dimer and fibrinogen in AF of different duration. 56 patients (group A) of 3,524 patients in whom the onset of AF had been witnessed in a chest pain clinic were enrolled for study. Plasma D-dimer and fibrinogen concentrations were checked within 30 min after the onset of AF and followed up as scheduled. Another 50 patients (group B) with chronic AF underwent the same protocol and served as controls. Results: In group A, the D-dimer levels reached a plateau at the 18th hour (382 ± 52 vs. 840 ± 280 ng/ml, p <0.001 by ANOVA) and the fibrinogen level increased gradually from 4.1 ± 0.6 g/ml at baseline to 6.1 ± 0.9 g/ml at the 48th hour (p <0.001). No subjects had evidence of intra-cardiac thrombi by trans-esophageal echocardiography. There were significant differences in plasma D-dimer and fibrinogen levels between the two groups at each measurement. At the cut-off value of 500 ng/ml, plasma D-dimer had a sensitivity of 100{\%}, a specificity of 93{\%} in defining AF lasting for less than 12 h. The positive and negative predictive values were 52{\%} and 100{\%}, respectively. Plasma D-dimer increased above the normal range prior to the 12th hour after the onset of AF. Conclusion: The observations support its use as a screening tool for identifying patients with short duration AF capable of being safely converted.",
keywords = "Atrial fibrillation, D-dimer, Fibrinogen, Thromboembolism",
author = "Wang, {Tzong Luen} and Hung, {Chi Ren} and Hang Chang",
year = "2004",
doi = "10.1159/000078410",
language = "English",
volume = "102",
pages = "115--118",
journal = "Cardiology",
issn = "0008-6312",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Evolution of plasma D-dimer and fibrinogen in witnessed onset of paroxysmal atrial fibrillation

AU - Wang, Tzong Luen

AU - Hung, Chi Ren

AU - Chang, Hang

PY - 2004

Y1 - 2004

N2 - Background: Although increased D-dimer and fibrinogen have been proved to be related with atrial fibrillation (AF), their evolution in the course of time remains unclear. Methods: To elucidate the evolution of plasma D-dimer and fibrinogen in AF of different duration. 56 patients (group A) of 3,524 patients in whom the onset of AF had been witnessed in a chest pain clinic were enrolled for study. Plasma D-dimer and fibrinogen concentrations were checked within 30 min after the onset of AF and followed up as scheduled. Another 50 patients (group B) with chronic AF underwent the same protocol and served as controls. Results: In group A, the D-dimer levels reached a plateau at the 18th hour (382 ± 52 vs. 840 ± 280 ng/ml, p <0.001 by ANOVA) and the fibrinogen level increased gradually from 4.1 ± 0.6 g/ml at baseline to 6.1 ± 0.9 g/ml at the 48th hour (p <0.001). No subjects had evidence of intra-cardiac thrombi by trans-esophageal echocardiography. There were significant differences in plasma D-dimer and fibrinogen levels between the two groups at each measurement. At the cut-off value of 500 ng/ml, plasma D-dimer had a sensitivity of 100%, a specificity of 93% in defining AF lasting for less than 12 h. The positive and negative predictive values were 52% and 100%, respectively. Plasma D-dimer increased above the normal range prior to the 12th hour after the onset of AF. Conclusion: The observations support its use as a screening tool for identifying patients with short duration AF capable of being safely converted.

AB - Background: Although increased D-dimer and fibrinogen have been proved to be related with atrial fibrillation (AF), their evolution in the course of time remains unclear. Methods: To elucidate the evolution of plasma D-dimer and fibrinogen in AF of different duration. 56 patients (group A) of 3,524 patients in whom the onset of AF had been witnessed in a chest pain clinic were enrolled for study. Plasma D-dimer and fibrinogen concentrations were checked within 30 min after the onset of AF and followed up as scheduled. Another 50 patients (group B) with chronic AF underwent the same protocol and served as controls. Results: In group A, the D-dimer levels reached a plateau at the 18th hour (382 ± 52 vs. 840 ± 280 ng/ml, p <0.001 by ANOVA) and the fibrinogen level increased gradually from 4.1 ± 0.6 g/ml at baseline to 6.1 ± 0.9 g/ml at the 48th hour (p <0.001). No subjects had evidence of intra-cardiac thrombi by trans-esophageal echocardiography. There were significant differences in plasma D-dimer and fibrinogen levels between the two groups at each measurement. At the cut-off value of 500 ng/ml, plasma D-dimer had a sensitivity of 100%, a specificity of 93% in defining AF lasting for less than 12 h. The positive and negative predictive values were 52% and 100%, respectively. Plasma D-dimer increased above the normal range prior to the 12th hour after the onset of AF. Conclusion: The observations support its use as a screening tool for identifying patients with short duration AF capable of being safely converted.

KW - Atrial fibrillation

KW - D-dimer

KW - Fibrinogen

KW - Thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=4043069372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4043069372&partnerID=8YFLogxK

U2 - 10.1159/000078410

DO - 10.1159/000078410

M3 - Article

VL - 102

SP - 115

EP - 118

JO - Cardiology

JF - Cardiology

SN - 0008-6312

IS - 2

ER -